NVO vs PFE — Performance Comparison
Side-by-side percent change for Novo Nordisk A/S (NVO), Pfizer Inc. (PFE) across every preset interval.
Over the past year, PFE is up 12.23% versus NVO down 32.79% — PFE ahead by 45.02%. Over the past 30 days, NVO is up 8.94% and PFE is down 6.71%. NVO trades at $44.46; PFE at $25.37.
| Ticker | Price | 1D | 3D | 7D | 30D | 90D | YTD | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk A/S | $44.46 | -2.93% | -5.40% | -3.49% | +8.94% ★ | -10.31% | -12.62% | -7.87% | -32.79% | -46.96% | +10.35% ★ |
| PFE Pfizer Inc. | $25.37 | -1.50% ★ | -1.95% ★ | -1.23% ★ | -6.71% | -8.03% ★ | +1.87% ★ | +1.22% ★ | +12.23% ★ | -31.46% ★ | -36.76% |
Want to zoom in?
Open the interactive Compare tool to overlay these tickers on a normalized chart, pin any two dates to see the exact return between them, and pick a custom interval.
Open in interactive CompareEach ticker's detail page
NVONovo Nordisk A/S
$44.46-2.93% today
PFEPfizer Inc.
$25.37-1.50% today